FDA orphan drug designation: treatment of Duchenne muscular dystrophy
All entries for: Precision BioSciences Inc. (PBI)
July 17, 2025
Precision BioSciences Inc. (PBI)
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of Duchenne muscular dystrophy